Data-driven Approaches to Healthcare Provider Resilience & Burnout During COVID-19 (NCT04922632) | Clinical Trial Compass
TerminatedNot Applicable
Data-driven Approaches to Healthcare Provider Resilience & Burnout During COVID-19
Stopped: Funding was exhausted
United States212 participantsStarted 2022-02-21
Plain-language summary
The United States is battling dual pandemics: healthcare provider (HCP) exhaustion and COVID-19. The COVID-19 pandemic death toll has surpassed 595,000 and continues to climb as the worldwide outbreak continues. Moreover, we have yet to understand the health impacts of "long-COVID". As evidenced by the national burnout epidemic in HCPs, persistent workplace stress not only impacts personal provider wellbeing, but also influences effective practice and patient outcomes.
To address this need, we propose a 4-year, multi-site, four-arm parallel-group randomized clinical trial (RCT) comparing 2 non-pharmacological interventions: Transcendental Meditation (TM) and Experience Resolution Methodology (ERM) to Treatment as Usual (TAU).
Participation in this study lasts up to 24 months for enrolled participants and is considered minimal risks.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Full-time HCPs
✓. A score of \>= 5 on the Subjective Units of Distress Scale (SUDS) at baseline visit.
✓. Willingness to address burnout symptoms by non-pharmacological means.
✓. Willingness to wear the provided wearable device (e.g., Apple, Empatica, and/or eSense) at the designated study visits and/or determined coaching sessions, as well as wear an Apple device, if eligible to receive an Apple watch, from baseline for the duration of the study (up to 24 months).
✓. Willingness to download the PatternHealth app on personal device.
Exclusion criteria
✕. Addition or change in dosage of psychotropic medications, beta-blockers, or anti-epileptic medications within the last 2 months
✕. HCPs may re-present for screening again after 2 months has passed since their last change in the medication categories listed that previously excluded them for re-evaluation for study eligibility.
✕. Current suicidal or homicidal ideation at the time of screening, as defined by the C-SSRS.
What they're measuring
1
Change in resilience as measured by the Connor-Davidson Resilience Scale-25